Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$9.0M
-24.3% from 2023
Prescriptions
1,712
$5,276.29 per claim
Patients
335
177 prescribers
Total spending, 2024
$9.0M
$26,964.21 per patient
Medicare prescription drug plans paid $9.0M for Avastin in 2024, for 1,712 prescriptions and refills to 335 patients (down 24.3% from 2023). The average cost per claim was $5,276.29.
California had the highest Medicare cost for Avastin in 2024: $2.8M for 496 claims, followed by Florida ($1.9M).
Mihran Shirinian, hematology-oncology in Glendale, CA, had the highest Medicare cost for Avastin in 2024: 156 claims costing $938K.
Avastin is made by Roche Holding AG (ROG.SW), listed in the Medicare spending data as Genentech, Inc..
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Mihran Shirinian Glendale, CA | Hematology-Oncology | 156 | 15 | $938K |
| Nader Javadi Calabasas, CA | Hematology-Oncology | 69 | 17 | $528K |
| Ghassan Al-Jazayrly |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 218 | 2,296 | 417 | $14.0M |
| 2023 | 174 | 2,024 | 341 | $11.9M |
| 2024 | 177 | 1,712 | 335 | $9.0M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology-Oncology |
| 57 |
| Under 11 |
| $244K |
| Syed S Rafique Greenwood, MS | Hematology-Oncology | 44 | Under 11 | $221K |
| Jason Tache Plantation, FL | Hematology-Oncology | 33 | Under 11 | $207K |
| Kirtan N Koticha Shreveport, LA | Hematology-Oncology | 28 | Under 11 | $201K |
| Swetha S Yadav Kearney, NE | Hematology-Oncology | 40 | Under 11 | $175K |
| Vinicio Hernandez Orlando, FL | Medical Oncology | 30 | Under 11 | $163K |
| Brian J Leberthon West Covina, CA | Hematology-Oncology | 32 | Under 11 | $159K |
| Asit J Choksi The Woodlands, TX | Hematology-Oncology | 21 | Under 11 | $144K |
| Samuel D Bailey Hazard, KY | Hematology-Oncology | 29 | Under 11 | $144K |
| Nelson A Matos-Fernandez Santa Isabel, PR | Hematology-Oncology | 32 | Under 11 | $137K |
| Antoine E Chahine Canfield, OH | Medical Oncology | 31 | Under 11 | $136K |
| Rohit Kapoor Live Oak, TX | Hematology-Oncology | 27 | Under 11 | $125K |
| Robert J Zieve Prescott, AZ | Family Practice | 14 | Under 11 | $124K |
| Amir A Rasheed Baytown, TX | Hematology-Oncology | 14 | Under 11 | $115K |
| James X Xu Rockville, MD | Hematology-Oncology | 15 | Under 11 | $114K |
| Kalpesh B Barot Orlando, FL | Hematology-Oncology | 14 | Under 11 | $111K |
| Anna M Di Marco Ponce, PR | Hematology-Oncology | 11 | Under 11 | $109K |
| Michael J McCleod Fort Myers, FL | Hematology-Oncology | 16 | Under 11 | $109K |
| Joel S Silver Hartford, CT | Hematology-Oncology | 22 | Under 11 | $101K |
| Pratibha K Desai Saint Petersburg, FL | Hematology-Oncology | 15 | Under 11 | $99K |
| Mamta V Vijayvargiya Orange City, FL | Hematology-Oncology | 11 | Under 11 | $98K |
| Afshin E Gabayan Beverly Hills, CA | Hematology-Oncology | 13 | Under 11 | $96K |
| Syed H Abid St Petersburg, FL | Medical Oncology | 12 | Under 11 | $88K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Genentech, Inc. ROG.SW | 1,712 | $9.0M |